DIA EUROPE is the largest event in the life science industry in Europe – the knowledge hub between science, healthcare, and regulation – and the place to meet trusted partners and network with the brightest minds who are passionate about advancing health priorities.
Wednesday 30th March from 2:20 PM to 2:40 PM
Strategic Safety and Pharmacovigilance
Azierta is back to face to face events, we will participate actively with a Live Content Hub Session about Strategic Safety and Pharmacovigilance:
One of the main challenges in early drug development is trying to define the safety profile of the molecule in question. Being able to predict what the safety scenario could be regarding our molecule could have a major impact in its early development. Defining strategies and methods to determine and predict the safety profile of molecules could greatly reduce the resources and increment the rate of success of the early development of any particular drug.
Senior Drug Safety Officer
Don´t miss out!
If you are not attending to DIA Europe but are interested on the content of the session or upcoming trends in Safety and Pharmacovigilance.
SUBSCRIBE FILLING THE FORM!
Or you can have a discussion with our experts on site or get some ideas about Azierta solutions requesting a meeting.
Regulatory Affairs, Pharmacovigilance, GXP Compliance & Safety Director